-
-
-
-
-
-
-
Pacira BioSciences Announces Notice of Allowance of New Patent for EXPAREL
-
-
-
-
-
-
-
Pacira Pharmaceuticals (PCRX) is Set to Break Out in 2020 - RBC Capital
-
-
-
-
-
-
-
Pacira Pharmaceuticals (PCRX) PT Lowered to $32 at BMO Capital
-
-
-
-
-
-
-
Pacira Pharmaceuticals Stock Trading Halted; FDA Advisory Committee to Review sNDA for EXPAREL® as a Nerve Block for Regional Analgesia
-
-
-
-
-
-
-
Pacira Pharma (PCRX) Says FDA Accepted sNDA for EXPAREL as Nerve Block to Produce Regional Analgesia
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

